Revelation Biosciences Inc (NASDAQ:REVB) currently has a daily average trading volume of 904.65K but it saw 4191895 shares traded in last market. With a market cap of 1.95M USD, the company’s current market price of $0.45 came falling about -3.41 while comparing to the previous closing price of $0.47. In past 52 weeks, the stock remained buoying in the range of price level as high as $25.26 and as low as $0.42. In the recent trading on the day, stock has struck highest price mark of $0.4233 while lowest mark touched by it was $0.5449.
Taking a look at 20-day trading activity of Revelation Biosciences Inc (REVB) gives us an average price of $0.7737, while its current price level is -98.20% below from 52-week high level whereas it is 8.07% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.8132 while that of 200 days or SMA-200 reads an average of $1.6489. A closer look into the stock’s movement over the week reveals that its volatility is standing at 29.12% during that period while stretching the period over a month that decreases to 13.39%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 31.28 which implies that the stock is in neutral territory.
Over the week, REVB’s stock price is moving -39.89% down while it is -48.22% when we observe its performance for the past one month. Year-to-date it is -96.98% down and over the past year, the stock is showing a downside performance of -97.52%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -35.72 beaten by the consensus estimate of -13.77 for the same. The company is expected to be releasing its next quarterly report in January, for which analysts forecasted an EPS of -0.64 while estimate for next year EPS is -7.48.
Currently, Revelation Biosciences Inc’s total number of outstanding shares is 4.29M. Company’s return on investment (ROI) stands at -580.33% and return on equity (ROE) at -270.02%. Stock’s beta reads 0.16. Stock has a price to book (P/B) ratio of 0.73. Its return on asset (ROA) is -148.06% on average.
